Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

STOCKWATCH: Currencies continue to confound earnings

This article was originally published in Scrip

Executive Summary

It is strange to think that while we work our way through the tail-end of the full-year 2014 earnings season, we are only about a month away from the start of next reporting period. The big issue that emerged at the start of the last earning season – the effects of foreign currency translations – is likely to worsen, particularly for those companies that couldn't bring themselves to give 2015 guidance in their last earnings announcement.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC028116

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel